ANVISA registration 80134860320Valid until Sep 15, 2035HIV, HBV AND HCV VIRUS NUCLEIC ACID
ANVISA Registration Number: 80134860320GRIFOLS BRASIL LTDAGRIFOLS DIAGNOSTICS SOLUTIONS INCRisk Class IV
Device names
- Technical name
- HIV, HBV AND HCV VIRUS NUCLEIC ACID
- Commercial name
- Discriminatory Probe Reagent kit (Procleix UltrioPlex E)
- Risk class
- Class IV
PT: ÁCIDO NUCLÉICO DE VÍRUS HIV, HBV E HCV
Registration details
- Registration Number
- 80134860320
- Process Number
- 25351457932202457
- CNPJ
- 02513899000171
Company information
- Registration Holder
- GRIFOLS BRASIL LTDA
- Manufacturer
- GRIFOLS DIAGNOSTICS SOLUTIONS INC
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Sep 15, 2025
- Validity
- 15/09/2035
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HIV, HBV AND HCV VIRUS NUCLEIC ACID in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80134860320 and manufactured by GRIFOLS DIAGNOSTICS SOLUTIONS INC. The registration is held by GRIFOLS BRASIL LTDA with validity until Sep 15, 2035.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.